ASPIRE BIOPHARMA HOLDINGS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $10.9M | $296.5M | $618.1K |
| Jun 2022 | $11.0M | $296.7M | $579.8K |
| Sep 2022 | $11.0M | $297.8M | $533.1K |
| Dec 2022 | $11.1M | $300.2M | $497.3K |
| Mar 2023 | $11.2M | $303.1M | $315.2K |
| Jun 2023 | $284.4K | $20.6M | $125.2K |
| Sep 2023 | $316.3K | $19.9M | $280 |
| Dec 2023 | $403.3K | $20.0M | $11.2K |
| Mar 2024 | $2.6M | $20.2M | $47.3K |
| Jun 2024 | $6.2M | $6.9M | $19.6K |
| Sep 2024 | $6.6M | $6.7M | $16.5K |
| Dec 2024 | $1.7M | $148.0K | $3.6K |
| Mar 2025 | $9.9M | $2.0M | $1.3M |
| Jun 2025 | $10.6M | $989.4K | $206.2K |
| Sep 2025 | $13.9M | $2.4M | $1.9M |
| Dec 2025 | $7.7M | $1.3M | $1.0M |
| Mar 2026 | $3.2M | $7.1M | $5.9M |
| Jun 2026 | $1.8M | $13.5M | $12.2M |